Check out what we’ve been up to and where we can connect!
September 16, 2020
The operational goal is to provide experienced oversight while advancing the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network toward long-term, local self-sustainability – to conduct high-quality research with a focus on emergent and high-impact public health research priorities in Liberia.
August 4, 2020
FHI Clinical is pleased to announce our partnership with Tiziana Life Sciences to expedite clinical development of TZLS-501, a novel fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb), for the treatment of COVID-19 (SARS-CoV-2) patients.
July 23, 2020
Claudia Christian of FHI Clinical recently spoke with the editor for Outsourcing-Pharma about the clinical services that FHI Clinical is providing to the Frederick National Laboratory for Cancer Research for the ongoing ACTT adaptive study allowing investigation of putative therapeutics for the treatment of COVID-19 in hospitalized adults.
July 14, 2020
FHI Clinical Inc. announced that it has a subcontract with the Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, Inc., to provide clinical operations services for the Adaptive COVID-19 Treatment Trial (ACTT). ACTT is an adaptive study to allow investigation of putative therapeutics, for the treatment of COVID-19 in hospitalized adults.
November 5-8, 2020
Attending WOCIP? Tafoya Hubbard and LaTonya Jones from FHI Clinical will be attending and would love to hear about your experiences in the pharmaceutical industry.
September 29, 2020
Register for this virtual plenary session at World Vaccine Congress Washington where panelists will discuss how to incorporate innovation into vaccine clinical trials, including how to apply information from the field to ongoing and future vaccine trials, use of real-world evidence for vaccine efficacy and regulatory perspectives in new development areas.
September 30, 2020
Register for this virtual roundtable at World Vaccine Congress Washington where attendees will discuss how to de-risk vaccine clinical trials in lower resource settings, both globally and within the United States, including how partnerships help achieve social impact.
September 28-October 1, 2020
Attending World Vaccine Congress Washington? Register for events at which our industry experts will be presenting or schedule a meeting with a team member who will be in attendance at the event.
September 16, 2020
In this webinar hosted by the African Academy of Sciences Clinical Trials Community (CTC), a range of stakeholders will discuss the importance of robust and efficient regulatory and ethics bodies for the clinical trial landscape, role of the WHO African Vaccine Regulatory Forum (AVAREF), and role of the CTC platform in enhancing collaborations and promoting efficiency through shared regulatory and ethics information.
August 11, 2020
Patient safety and data integrity remain of utmost importance as CROs navigate shifting regulatory guidelines, reevaluate their existing strategies and reprioritize IT projects. Register to learn how the pandemic has transformed the clinical trial landscape, the operational shifts that are needed within CROs, the technologies that have been most impactful and some of the obstacles and barriers to transformation.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA